{reportSlug=global-kidney-cancer-drugs-market, reportId=25128, mktKeyword=Kidney Cancer Drugs, cagr=0.00, publishDate=Mar 2024, priceOption2=6800, reportTitle=Kidney Cancer Drugs Comprehensive Study by Type (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Torisel (Temsirolimus), Proleukin (Aldesleukin), Other), Application (Hospitals, Clinics, Research Center, Other), Therapy (Targeted Therapy, Chemotherapy, Immunotherapy) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=225, priceOption1=3650, forecastYr=2030, noOfPages=238, reportKey=24875, breadcrum=Global Kidney Cancer Drugs}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Mar 2024 238 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales